This is a type of leukemia that affects the bone marrow, where blood cells are made. It involves too many immature red blood cells and white blood cells, and some are abnormal.
Every report comes from a Lived member, sent anonymously.
Have you had Stem Cell Transplant for Acute Erythroid Leukemia?
Acute erythroid leukemia (AEL), once called erythroleukemia or Di Guglielmo disease, is a rare and aggressive form of acute myeloid leukemia (AML). AML is a cancer of the bone marrow, the spongy tissue inside bones where blood cells are made. In this subtype, the marrow fills with abnormal, immature cells that were meant to become red blood cells. These cells never mature, and they crowd out the healthy cells that carry oxygen, fight infection and help blood clot. The result is usually severe anemia (a shortage of red blood cells), which causes tiredness, paleness and breathlessness, along with fevers, infections, and easy bruising or bleeding. AEL makes up only about 2% of AML cases. Its definition has changed several times, and some specialists now group most cases under a broader label, AML with a TP53 mutation, so you may hear more than one name for the same diagnosis.
AEL begins when bone marrow cells acquire genetic changes that let them multiply without maturing. Most cases are tied to damage in TP53, a gene that normally stops cells with injured DNA from dividing, and the leukemia cells usually carry several chromosome abnormalities at once. Many cases appear without any earlier blood disorder. Others develop from a previous bone marrow condition, such as myelodysplastic syndrome (MDS, a disorder in which the marrow makes poorly formed blood cells), or after chemotherapy or radiation for another cancer. Risk rises with age, and the condition is more common in men. Benzene exposure and inherited gene variants have been suggested as contributors, but no lifestyle or environmental cause has been firmly established, and most people cannot point to anything that caused their illness.
Blood tests are usually the first clue. A complete blood count (CBC) often shows low red cells, and frequently low white cells and platelets too. Abnormal cells may or may not appear in the blood, so a normal-looking smear does not rule out the disease. A bone marrow test confirms the diagnosis. A small sample of marrow and bone is taken with a needle and examined under the microscope and with special stains that show which cells are of red cell origin. Under the current World Health Organization definition, AEL means that erythroid (red cell) precursors make up at least 80% of the marrow cells, with at least 30% of them at the earliest, least mature stage. Genetic tests on the marrow look for TP53 mutations and chromosome changes. These results matter beyond confirming the name: they help predict how the leukemia will respond and guide treatment choices. Doctors also ask about earlier blood disorders and past cancer treatment, because these change how the case is classified and what outcome is likely.
Treatment follows the general approach to high-risk AML, adjusted for age, overall health and the person's goals. Because AEL is rare, there are no large trials devoted to it, and specialists often recommend a clinical trial as a strong option when one is available. Intensive chemotherapy, usually given in the hospital over several weeks, aims to clear the leukemia from the marrow and bring about remission (no detectable leukemia on standard tests). It is generally offered to people healthy enough to tolerate it. For people who are older or less fit, lower-intensity treatment with a hypomethylating agent such as azacitidine or decitabine, drugs that help reactivate genes the leukemia has switched off, may control the disease for a time. Responses to both approaches are often short-lived. Venetoclax, a targeted pill that has improved results in many forms of AML, appears to work less well in this subtype. An allogeneic stem cell transplant, which replaces the person's bone marrow with cells from a matched donor, is the only treatment that offers a chance of long-term cure. It requires first reaching a deep remission and being fit enough for a demanding procedure, so only a minority of people are able to have one. Supportive care is central throughout. Red blood cell and platelet transfusions replace the cells the leukemia and its treatment destroy, and antibiotics and antifungal medicines prevent or treat infections. Palliative care can be part of the plan at any stage to manage symptoms and help with difficult decisions.
AEL is one of the most serious forms of leukemia, and outlook is generally poor. In published studies, median survival in adults has ranged from about 3 to 9 months, although these figures mix older definitions and individual outcomes vary. Age makes a large difference: children and younger adults tend to do considerably better than older adults, and people whose leukemia arose on its own fare somewhat better than those whose disease followed MDS or earlier cancer treatment. Those who reach remission and go on to transplant have the best chance of long-term survival. Treatment brings frequent hospital visits, regular blood counts, and often hospital stays during intensive chemotherapy. Low blood counts can last weeks at a time, making fatigue, transfusions and precautions against infection a regular part of life. Because the outlook is serious, many people find it helpful to talk early with their team about goals, what each option realistically offers, and how to balance time in treatment against quality of life.
See a doctor promptly for unexplained, persistent tiredness or paleness, frequent fevers or infections, easy bruising, nosebleeds or bleeding gums, or tiny red dots on the skin. A blood count can quickly show whether a marrow problem needs further testing. During treatment, call your care team right away for a fever of 100.5°F (38°C) or higher, shaking chills, or redness and swelling where a catheter enters the skin. Infections when white cell counts are low can be life threatening and need urgent attention, so ask your team in advance exactly whom to call and when to go straight to the hospital.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Acute Erythroid Leukemia is like, what's helped you, or ask the community a question.